WES analysis of TCS627 did indicate a mutation in WNT7A, a factor that can activate the canonical and non-canonical Wnt pathways described as a tumor suppressor in lung cancer but also as an oncogene in ovarian, breast and brain tumors [51,52]. The gene discussed is WNT7A; the disease is brain neoplasm.